French agency seeks standard use of special healthcare products:
This article was originally published in Clinica
Executive Summary
The French healthcare products safety agency, AFSSAPS, issued an update on September 8 concerning the use in French hospitals of products that are reimbursed separately from the diagnosis-related group scheme (where most health procedures are paid for as standard stay groups - GHSs). The agency is seeking to ensure that all hospitals that use these products conform to the same criteria. To this aim, it is in the process - working along with the Supreme Health Authority (HAS) and the National Cancer Institute (INCa) - of drawing up reference standards that are to be posted on the websites of the three organisations. The update is on the availability of information on pharmaceuticals, but is also a reminder that more uniform criteria are soon to be applied.